BAY 86-6150: Phase II/III discontinued

Bayer discontinued the 2-part, open-label, international Phase II/III TRUST trial comparing BAY 86-6150 vs. eptacog alfa in about 65 patients with hemophilia A or B who have developed inhibitors due t...